C₁₇H₃₀N₆O₆ · 414.46 g/mol
Prostamax
Prostamax is a synthetic tetrapeptide bioregulator developed by Russian researcher Vladimir Khavinson. Like other bioregulators in the Khavinson series, it consists of a short peptide sequence proposed in Russian research to act on tissue-specific gene expression — in this case, prostate tissue. Studied in animal models of age-related prostate changes and benign prostatic hyperplasia.
Research Areas
- •Prostate tissue bioregulation
- •BPH animal models
- •Khavinson peptide system
Molecular Specifications
Molecular Formula
C₁₇H₃₀N₆O₆
Molecular Weight
414.46 g/mol
Purity
≥98.0%
Sequence
Lys-Glu-Asp-Pro
Select Size
Prices are subject to change. Final pricing will be confirmed at checkout.
Certificates of Analysis
Current batch test results for Prostamax. Click any row to download the full lab report PDF — third-party HPLC, USP<85> endotoxin, and USP<71> microbial testing.
| Size | Batch | Test Date | Purity | Endotox | Sterility | |
|---|---|---|---|---|---|---|
| 25mg | PC-G-PROS | 04/22/2026 | 99.34% | Pass | Pass | View PDF |
You May Also Like
GHK-Cu (Copper Peptide)
Copper-binding tripeptide with remarkable anti-aging research profile.
From $64.99
View DetailsEpithalon (Epitalon)
Tetrapeptide for telomerase and longevity research.
From $149.99
View DetailsKLOW Blend
Advanced regenerative blend of GHK-Cu, BPC-157, TB-500, and KPV for longevity research.
From $123.99
View Details